BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27138926)

  • 1. Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia.
    Alquezar C; Salado IG; de la Encarnación A; Pérez DI; Moreno F; Gil C; de Munain AL; Martínez A; Martín-Requero Á
    Mol Neurodegener; 2016 Apr; 11(1):36. PubMed ID: 27138926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
    Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment.
    Martínez-González L; Rodríguez-Cueto C; Cabezudo D; Bartolomé F; Andrés-Benito P; Ferrer I; Gil C; Martín-Requero Á; Fernández-Ruiz J; Martínez A; de Lago E
    Sci Rep; 2020 Mar; 10(1):4449. PubMed ID: 32157143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions.
    Rodríguez-Periñán G; de la Encarnación A; Moreno F; López de Munain A; Martínez A; Martín-Requero Á; Alquézar C; Bartolomé F
    Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers.
    Alquézar C; Esteras N; de la Encarnación A; Alzualde A; Moreno F; López de Munain A; Martín-Requero A
    Neurobiol Aging; 2014 Apr; 35(4):886-98. PubMed ID: 24139281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia.
    Alquezar C; Esteras N; Bartolomé F; Merino JJ; Alzualde A; López de Munain A; Martín-Requero Á
    Neurobiol Aging; 2012 Feb; 33(2):429.e7-20. PubMed ID: 21232819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
    Alquezar C; Esteras N; Alzualde A; Moreno F; Ayuso MS; López de Munain A; Martín-Requero Á
    PLoS One; 2012; 7(5):e37057. PubMed ID: 22623979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS).
    Vaca G; Martinez-Gonzalez L; Fernandez A; Rojas-Prats E; Porras G; Cuevas EP; Gil C; Martinez A; Martin-Requero Á
    J Neurochem; 2021 Feb; 156(3):379-390. PubMed ID: 32628315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as neuroprotective agents.
    Joshi K; Goyal S; Grover S; Jamal S; Singh A; Dhar P; Grover A
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):515. PubMed ID: 28155653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.
    Chitramuthu BP; Bennett HPJ; Bateman A
    Brain; 2017 Dec; 140(12):3081-3104. PubMed ID: 29053785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.
    de la Encarnación A; Alquézar C; Martín-Requero Á
    Mol Neurobiol; 2016 Dec; 53(10):7107-7118. PubMed ID: 26676574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43.
    Nonaka T; Suzuki G; Tanaka Y; Kametani F; Hirai S; Okado H; Miyashita T; Saitoe M; Akiyama H; Masai H; Hasegawa M
    J Biol Chem; 2016 Mar; 291(11):5473-5483. PubMed ID: 26769969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.
    Pottier C; Mateiu L; Baker MC; DeJesus-Hernandez M; Teixeira Vicente C; Finch NA; Tian S; van Blitterswijk M; Murray ME; Ren Y; Petrucelli L; Oskarsson B; Biernacka JM; Graff-Radford NR; Boeve BF; Petersen RC; Josephs KA; Asmann YW; Dickson DW; Rademakers R
    Brain; 2022 Jul; 145(7):2472-2485. PubMed ID: 34918030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients.
    Posa D; Martínez-González L; Bartolomé F; Nagaraj S; Porras G; Martínez A; Martín-Requero Á
    Mol Neurobiol; 2019 Apr; 56(4):2424-2432. PubMed ID: 30030753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.
    Redenti S; Marcovich I; De Vita T; Pérez C; De Zorzi R; Demitri N; Perez DI; Bottegoni G; Bisignano P; Bissaro M; Moro S; Martinez A; Storici P; Spalluto G; Cavalli A; Federico S
    ChemMedChem; 2019 Feb; 14(3):310-314. PubMed ID: 30548443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach.
    Sharma V; Chander Sharma P; Reang J; Yadav V; Kumar Tonk R; Majeed J; Sharma K
    Bioorg Chem; 2024 Jun; 147():107378. PubMed ID: 38643562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.
    Ward ME; Taubes A; Chen R; Miller BL; Sephton CF; Gelfand JM; Minami S; Boscardin J; Martens LH; Seeley WW; Yu G; Herz J; Filiano AJ; Arrant AE; Roberson ED; Kraft TW; Farese RV; Green A; Gan L
    J Exp Med; 2014 Sep; 211(10):1937-45. PubMed ID: 25155018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
    Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
    Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.